CINXE.COM

<!DOCTYPE html> <html lang="en-US" class="no-js"> <head>  <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="0192e7ff-6cd0-7eeb-a526-454b4ec9d90f" ></script> <script type="text/javascript"> function OptanonWrapper() { } </script>  <meta charset="UTF-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0"> <link rel="profile" href="http://gmpg.org/xfn/11"> <link rel="pingback" href="https://tinygems.com/xmlrpc.php">  <link rel="shortcut icon" href="https://tinygems.com/wp-content/themes/tinygems/favicon.ico" /> <meta property="og:image" content="https://tinygems.com/wp-content/themes/tinygems/fb-og-cnw.png" /> <link rel="stylesheet" href="https://tinygems.com/wp-content/themes/tinygems/css/angular-styles.css?1732373182" /> <link rel="stylesheet" href="https://tinygems.com/wp-content/themes/tinygems/js/fancyBox/source/jquery.fancybox.css" /> <link rel="apple-touch-icon-precomposed" href="https://tinygems.com/wp-content/themes/tinygems/ios-icon.png"/> <script src="https://ajax.googleapis.com/ajax/libs/angularjs/1.5.7/angular.min.js"></script> <script src="//ajax.googleapis.com/ajax/libs/angularjs/1.5.7/angular-animate.js"></script>  <link rel="stylesheet" href="https://use.typekit.net/xip4tqq.css"> <script>(function(html){html.className = html.className.replace(/\bno-js\b/,'js')})(document.documentElement);</script> <meta name='robots' content='index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1' />  <title>Calidi Biotherapeutics Inc. (NYSE American: CLDI) Shares Data Supporting Innovative Proprietary Systemic Antitumor Platform - TinyGems</title> <link rel="canonical" href="https://tinygems.com/calidi-biotherapeutics-inc-nyse-american-cldi-shares-data-supporting-innovative-proprietary-systemic-antitumor-platform/" /> <meta property="og:locale" content="en_US" /> <meta property="og:type" content="article" /> <meta property="og:title" content="Calidi Biotherapeutics Inc. (NYSE American: CLDI) Shares Data Supporting Innovative Proprietary Systemic Antitumor Platform - TinyGems" /> <meta property="og:description" content="The American Cancer Society (“ACA”) has projected that 2024 will be the first year ever to see two million people diagnosed with cancer, which remains the second leading cause of death in the United States, after heart disease (https://ibn.fm/ADo2Q). Companies such as Calidi Biotherapeutics (NYSE American: CLDI) are working hard to discover more effective treatments … Continue reading "Calidi Biotherapeutics Inc. (NYSE American: CLDI) Shares Data Supporting Innovative Proprietary Systemic Antitumor Platform"" /> <meta property="og:url" content="https://tinygems.com/calidi-biotherapeutics-inc-nyse-american-cldi-shares-data-supporting-innovative-proprietary-systemic-antitumor-platform/" /> <meta property="og:site_name" content="TinyGems" /> <meta property="article:publisher" content="https://www.facebook.com/tinygems.com" /> <meta property="article:published_time" content="2024-11-22T13:00:00+00:00" /> <meta property="article:modified_time" content="2024-11-22T18:18:23+00:00" /> <meta name="author" content="Christian Amiscua" /> <meta name="twitter:card" content="summary_large_image" /> <meta name="twitter:creator" content="@tinygems" /> <meta name="twitter:site" content="@tinygems" /> <meta name="twitter:label1" content="Written by" /> <meta name="twitter:data1" content="Christian Amiscua" /> <meta name="twitter:label2" content="Est. reading time" /> <meta name="twitter:data2" content="5 minutes" /> <script type="application/ld+json" class="yoast-schema-graph">{"@context":"https://schema.org","@graph":[{"@type":"Article","@id":"https://tinygems.com/calidi-biotherapeutics-inc-nyse-american-cldi-shares-data-supporting-innovative-proprietary-systemic-antitumor-platform/#article","isPartOf":{"@id":"https://tinygems.com/calidi-biotherapeutics-inc-nyse-american-cldi-shares-data-supporting-innovative-proprietary-systemic-antitumor-platform/"},"author":{"name":"Christian Amiscua","@id":"https://tinygems.com/#/schema/person/d63601243e945851080e09e3984c0baa"},"headline":"Calidi Biotherapeutics Inc. (NYSE American: CLDI) Shares Data Supporting Innovative Proprietary Systemic Antitumor Platform","datePublished":"2024-11-22T13:00:00+00:00","dateModified":"2024-11-22T18:18:23+00:00","mainEntityOfPage":{"@id":"https://tinygems.com/calidi-biotherapeutics-inc-nyse-american-cldi-shares-data-supporting-innovative-proprietary-systemic-antitumor-platform/"},"wordCount":1027,"publisher":{"@id":"https://tinygems.com/#organization"},"articleSection":["Tiny Gem"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https://tinygems.com/calidi-biotherapeutics-inc-nyse-american-cldi-shares-data-supporting-innovative-proprietary-systemic-antitumor-platform/","url":"https://tinygems.com/calidi-biotherapeutics-inc-nyse-american-cldi-shares-data-supporting-innovative-proprietary-systemic-antitumor-platform/","name":"Calidi Biotherapeutics Inc. (NYSE American: CLDI) Shares Data Supporting Innovative Proprietary Systemic Antitumor Platform - TinyGems","isPartOf":{"@id":"https://tinygems.com/#website"},"datePublished":"2024-11-22T13:00:00+00:00","dateModified":"2024-11-22T18:18:23+00:00","breadcrumb":{"@id":"https://tinygems.com/calidi-biotherapeutics-inc-nyse-american-cldi-shares-data-supporting-innovative-proprietary-systemic-antitumor-platform/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https://tinygems.com/calidi-biotherapeutics-inc-nyse-american-cldi-shares-data-supporting-innovative-proprietary-systemic-antitumor-platform/"]}]},{"@type":"BreadcrumbList","@id":"https://tinygems.com/calidi-biotherapeutics-inc-nyse-american-cldi-shares-data-supporting-innovative-proprietary-systemic-antitumor-platform/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://tinygems.com/"},{"@type":"ListItem","position":2,"name":"NewsRoom Articles","item":"https://tinygems.com/newsroom/newsroom-articles/"},{"@type":"ListItem","position":3,"name":"Calidi Biotherapeutics Inc. (NYSE American: CLDI) Shares Data Supporting Innovative Proprietary Systemic Antitumor Platform"}]},{"@type":"WebSite","@id":"https://tinygems.com/#website","url":"https://tinygems.com/","name":"TinyGems","description":"Spotlighting undiscovered companies with enormous upside potential.","publisher":{"@id":"https://tinygems.com/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://tinygems.com/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https://tinygems.com/#organization","name":"TinyGems","url":"https://tinygems.com/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https://tinygems.com/#/schema/logo/image/","url":"https://tinygems.com/wp-content/uploads/tg-amp-logo.png","contentUrl":"https://tinygems.com/wp-content/uploads/tg-amp-logo.png","width":190,"height":142,"caption":"TinyGems"},"image":{"@id":"https://tinygems.com/#/schema/logo/image/"},"sameAs":["https://www.facebook.com/tinygems.com","https://twitter.com/tinygems"]},{"@type":"Person","@id":"https://tinygems.com/#/schema/person/d63601243e945851080e09e3984c0baa","name":"Christian Amiscua","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https://tinygems.com/#/schema/person/image/","url":"https://secure.gravatar.com/avatar/8a84f51d57cade327d2817ae67a6d290?s=96&d=mm&r=g","contentUrl":"https://secure.gravatar.com/avatar/8a84f51d57cade327d2817ae67a6d290?s=96&d=mm&r=g","caption":"Christian Amiscua"},"url":"https://tinygems.com/author/tg_ibn_christian/"}]}</script>  <link rel="amphtml" href="https://tinygems.com/calidi-biotherapeutics-inc-nyse-american-cldi-shares-data-supporting-innovative-proprietary-systemic-antitumor-platform/amp/" /><meta name="generator" content="AMP for WP 1.0.98"/><link rel='dns-prefetch' href='//ajax.googleapis.com' /> <link rel='dns-prefetch' href='//cdnjs.cloudflare.com' /> <link rel='stylesheet' id='wp-block-library-css' href='https://tinygems.com/wp-includes/css/dist/block-library/style.min.css' type='text/css' media='all' /> <style id='classic-theme-styles-inline-css' type='text/css'> /*! This file is auto-generated */ .wp-block-button__link{color:#fff;background-color:#32373c;border-radius:9999px;box-shadow:none;text-decoration:none;padding:calc(.667em + 2px) calc(1.333em + 2px);font-size:1.125em}.wp-block-file__button{background:#32373c;color:#fff;text-decoration:none} </style> <style id='global-styles-inline-css' type='text/css'> body{--wp--preset--color--black: #000000;--wp--preset--color--cyan-bluish-gray: #abb8c3;--wp--preset--color--white: #ffffff;--wp--preset--color--pale-pink: #f78da7;--wp--preset--color--vivid-red: #cf2e2e;--wp--preset--color--luminous-vivid-orange: #ff6900;--wp--preset--color--luminous-vivid-amber: #fcb900;--wp--preset--color--light-green-cyan: #7bdcb5;--wp--preset--color--vivid-green-cyan: #00d084;--wp--preset--color--pale-cyan-blue: #8ed1fc;--wp--preset--color--vivid-cyan-blue: #0693e3;--wp--preset--color--vivid-purple: #9b51e0;--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple: linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%);--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan: linear-gradient(135deg,rgb(122,220,180) 0%,rgb(0,208,130) 100%);--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange: linear-gradient(135deg,rgba(252,185,0,1) 0%,rgba(255,105,0,1) 100%);--wp--preset--gradient--luminous-vivid-orange-to-vivid-red: linear-gradient(135deg,rgba(255,105,0,1) 0%,rgb(207,46,46) 100%);--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray: linear-gradient(135deg,rgb(238,238,238) 0%,rgb(169,184,195) 100%);--wp--preset--gradient--cool-to-warm-spectrum: linear-gradient(135deg,rgb(74,234,220) 0%,rgb(151,120,209) 20%,rgb(207,42,186) 40%,rgb(238,44,130) 60%,rgb(251,105,98) 80%,rgb(254,248,76) 100%);--wp--preset--gradient--blush-light-purple: linear-gradient(135deg,rgb(255,206,236) 0%,rgb(152,150,240) 100%);--wp--preset--gradient--blush-bordeaux: linear-gradient(135deg,rgb(254,205,165) 0%,rgb(254,45,45) 50%,rgb(107,0,62) 100%);--wp--preset--gradient--luminous-dusk: linear-gradient(135deg,rgb(255,203,112) 0%,rgb(199,81,192) 50%,rgb(65,88,208) 100%);--wp--preset--gradient--pale-ocean: linear-gradient(135deg,rgb(255,245,203) 0%,rgb(182,227,212) 50%,rgb(51,167,181) 100%);--wp--preset--gradient--electric-grass: linear-gradient(135deg,rgb(202,248,128) 0%,rgb(113,206,126) 100%);--wp--preset--gradient--midnight: linear-gradient(135deg,rgb(2,3,129) 0%,rgb(40,116,252) 100%);--wp--preset--font-size--small: 13px;--wp--preset--font-size--medium: 20px;--wp--preset--font-size--large: 36px;--wp--preset--font-size--x-large: 42px;--wp--preset--spacing--20: 0.44rem;--wp--preset--spacing--30: 0.67rem;--wp--preset--spacing--40: 1rem;--wp--preset--spacing--50: 1.5rem;--wp--preset--spacing--60: 2.25rem;--wp--preset--spacing--70: 3.38rem;--wp--preset--spacing--80: 5.06rem;--wp--preset--shadow--natural: 6px 6px 9px rgba(0, 0, 0, 0.2);--wp--preset--shadow--deep: 12px 12px 50px rgba(0, 0, 0, 0.4);--wp--preset--shadow--sharp: 6px 6px 0px rgba(0, 0, 0, 0.2);--wp--preset--shadow--outlined: 6px 6px 0px -3px rgba(255, 255, 255, 1), 6px 6px rgba(0, 0, 0, 1);--wp--preset--shadow--crisp: 6px 6px 0px rgba(0, 0, 0, 1);}:where(.is-layout-flex){gap: 0.5em;}:where(.is-layout-grid){gap: 0.5em;}body .is-layout-flow > .alignleft{float: left;margin-inline-start: 0;margin-inline-end: 2em;}body .is-layout-flow > .alignright{float: right;margin-inline-start: 2em;margin-inline-end: 0;}body .is-layout-flow > .aligncenter{margin-left: auto !important;margin-right: auto !important;}body .is-layout-constrained > .alignleft{float: left;margin-inline-start: 0;margin-inline-end: 2em;}body .is-layout-constrained > .alignright{float: right;margin-inline-start: 2em;margin-inline-end: 0;}body .is-layout-constrained > .aligncenter{margin-left: auto !important;margin-right: auto !important;}body .is-layout-constrained > :where(:not(.alignleft):not(.alignright):not(.alignfull)){max-width: var(--wp--style--global--content-size);margin-left: auto !important;margin-right: auto !important;}body .is-layout-constrained > .alignwide{max-width: var(--wp--style--global--wide-size);}body .is-layout-flex{display: flex;}body .is-layout-flex{flex-wrap: wrap;align-items: center;}body .is-layout-flex > *{margin: 0;}body .is-layout-grid{display: grid;}body .is-layout-grid > *{margin: 0;}:where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;}:where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;}.has-black-color{color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-color{color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-color{color: var(--wp--preset--color--white) !important;}.has-pale-pink-color{color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-color{color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-color{color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-color{color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-color{color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-color{color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-color{color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-color{color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-color{color: var(--wp--preset--color--vivid-purple) !important;}.has-black-background-color{background-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-background-color{background-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-background-color{background-color: var(--wp--preset--color--white) !important;}.has-pale-pink-background-color{background-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-background-color{background-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-background-color{background-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-background-color{background-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-background-color{background-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-background-color{background-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-background-color{background-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-background-color{background-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-background-color{background-color: var(--wp--preset--color--vivid-purple) !important;}.has-black-border-color{border-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-border-color{border-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-border-color{border-color: var(--wp--preset--color--white) !important;}.has-pale-pink-border-color{border-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-border-color{border-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-border-color{border-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-border-color{border-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-border-color{border-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-border-color{border-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-border-color{border-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-border-color{border-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-border-color{border-color: var(--wp--preset--color--vivid-purple) !important;}.has-vivid-cyan-blue-to-vivid-purple-gradient-background{background: var(--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple) !important;}.has-light-green-cyan-to-vivid-green-cyan-gradient-background{background: var(--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan) !important;}.has-luminous-vivid-amber-to-luminous-vivid-orange-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange) !important;}.has-luminous-vivid-orange-to-vivid-red-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-orange-to-vivid-red) !important;}.has-very-light-gray-to-cyan-bluish-gray-gradient-background{background: var(--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray) !important;}.has-cool-to-warm-spectrum-gradient-background{background: var(--wp--preset--gradient--cool-to-warm-spectrum) !important;}.has-blush-light-purple-gradient-background{background: var(--wp--preset--gradient--blush-light-purple) !important;}.has-blush-bordeaux-gradient-background{background: var(--wp--preset--gradient--blush-bordeaux) !important;}.has-luminous-dusk-gradient-background{background: var(--wp--preset--gradient--luminous-dusk) !important;}.has-pale-ocean-gradient-background{background: var(--wp--preset--gradient--pale-ocean) !important;}.has-electric-grass-gradient-background{background: var(--wp--preset--gradient--electric-grass) !important;}.has-midnight-gradient-background{background: var(--wp--preset--gradient--midnight) !important;}.has-small-font-size{font-size: var(--wp--preset--font-size--small) !important;}.has-medium-font-size{font-size: var(--wp--preset--font-size--medium) !important;}.has-large-font-size{font-size: var(--wp--preset--font-size--large) !important;}.has-x-large-font-size{font-size: var(--wp--preset--font-size--x-large) !important;} .wp-block-navigation a:where(:not(.wp-element-button)){color: inherit;} :where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;} :where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;} .wp-block-pullquote{font-size: 1.5em;line-height: 1.6;} </style> <link rel='stylesheet' id='contact-form-7-css' href='https://tinygems.com/wp-content/plugins/contact-form-7/includes/css/styles.css' type='text/css' media='all' /> <link rel='stylesheet' id='genericons-css' href='https://tinygems.com/wp-content/themes/tinygems/genericons/genericons.css' type='text/css' media='all' /> <link rel='stylesheet' id='font-awesome-css' href='https://tinygems.com/wp-content/themes/tinygems/css/fontawesome-all.min.css' type='text/css' media='all' /> <link rel='stylesheet' id='tinygems-style-css' href='https://tinygems.com/wp-content/themes/tinygems/style.css' type='text/css' media='all' /> <link rel='stylesheet' id='customstyles-css' href='https://tinygems.com/wp-content/themes/tinygems/css/styles.css?1732373182' type='text/css' media='all' /> <link rel='stylesheet' id='tablepress-default-css' href='https://tinygems.com/wp-content/plugins/tablepress/css/build/default.css' type='text/css' media='all' /> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/jquery/jquery.min.js" id="jquery-core-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/jquery/jquery-migrate.min.js" id="jquery-migrate-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/fancyBox/source/jquery.fancybox.js" id="fancy-js"></script> <script type="text/javascript" src="//ajax.googleapis.com/ajax/libs/angularjs/1.5.7/angular-resource.js" id="ngresource-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/ng-lodash-master/build/ng-lodash.min.js" id="nglodash-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/moment.min.js" id="moment_min-js"></script> <script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/angular-moment/1.0.0-beta.6/angular-moment.min.js" id="ngmoment-js"></script>  <link rel="https://api.w.org/" href="https://tinygems.com/wp-json/" /><link rel="alternate" type="application/json" href="https://tinygems.com/wp-json/wp/v2/posts/40379" /><link rel='shortlink' href='https://tinygems.com/?p=40379' /> <link rel="alternate" type="application/json+oembed" href="https://tinygems.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Ftinygems.com%2Fcalidi-biotherapeutics-inc-nyse-american-cldi-shares-data-supporting-innovative-proprietary-systemic-antitumor-platform%2F" /> <link rel="alternate" type="text/xml+oembed" href="https://tinygems.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Ftinygems.com%2Fcalidi-biotherapeutics-inc-nyse-american-cldi-shares-data-supporting-innovative-proprietary-systemic-antitumor-platform%2F&format=xml" />  <script async src="https://www.googletagmanager.com/gtag/js?id=G-X56RVJCEJS"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-X56RVJCEJS'); </script>  <script async src="https://tag.pearldiver.io/ldc.js?pid=7315ce62cb84c70d74b0564eb49eda9b&aid=16de03f2"></script> </head> <body class="post-template-default single single-post postid-40379 single-format-standard group-blog">   <div class="banner"> <div class="container"> <div class="logo"><a href="https://tinygems.com/"><img src="https://tinygems.com/wp-content/themes/tinygems/images/tinygems.png" alt="tinygems Logo"/></a></div> <div class="banner-right"> <h3>Spotlighting undiscovered companies with enormous upside potential.</h3> <div class="banner-right-flex"> <h4>Contact us: <span>(310) 299-1717</span></h4> <div class="social"> <ul> <li class="twitter"><a href="https://twitter.com/tinygems" target="_blank" rel="nofollow"></a></li> <li class="linkedin"><a href="https://www.linkedin.com/company/5133985?trk=tyah&trkInfo=tarId%3A1402372889813%2Ctas%3Atinygem%2Cidx%3A1-1-1" target="_blank" rel="nofollow"></a></li> <li class="facebook"><a href="https://www.facebook.com/tinygems.net" target="_blank" rel="nofollow"></a></li> </ul> </div></div> </div>  <div id="hamburger"><span>Spotlighting undiscovered companies with enormous upside potential.</span></div> <div id="Menu"> <div class="menu-main-navigation-container"><ul id="menu-main-navigation" class="menu"><li id="menu-item-31636" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-home menu-item-31636"><a href="https://tinygems.com/">Home</a></li> <li id="menu-item-51" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-51"><a href="https://tinygems.com/about/">About</a></li> <li id="menu-item-5539" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-5539"><a href="https://tinygems.com/tiny-gems/">Tiny Gems</a></li> <li id="menu-item-17" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-17"><a href="https://tinygems.com/newsroom/">NewsRoom</a></li> <li id="menu-item-34478" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-34478"><a href="https://tinygems.com/newsletter-archives/">Newsletter Archives</a></li> <li id="menu-item-34872" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-34872"><a target="_blank" rel="noopener" href="https://www.investorbrandnetwork.com/events/">Events</a></li> <li id="menu-item-49" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-49"><a href="https://tinygems.com/contact/">Contact</a></li> </ul></div> </div> </div> </div>  <div class="article-headlines"> <div class="container"> <div class="headlines-label"><a href="/newsroom/newsroom-articles/">Headlines</a></div> <div id="Headline"> <div class="cycle-slideshow" data-cycle-fx="scrollVert" data-cycle-timeout="5000" data-cycle-slides="> div">  <div> <a href="/gemxx-corp-gemz-announces-definitive-agreement-with-latin-energy-partners-in-strategic-latin-america-venture/">GEMXX Corp. (GEMZ) Announces Definitive Agreement with Latin Energy Partners in Strategic Latin America Venture</a> </div><div> <a href="/mullen-automotive-inc-nasdaq-muln-subsidiary-announces-first-dealership-deal-in-market-projected-to-see-record-sales/">Mullen Automotive Inc. (MULN) Subsidiary Announces First Dealership Deal in Market Projected to See Record Sales</a> </div><div> <a href="/lexaria-bioscience-corp-nasdaq-lexx-hires-new-ceo-amid-shift-in-focus-to-pharmaceutical-industry-collaboration-and-operations/">Lexaria Bioscience Corp. (LEXX) Hires New CEO in Focus to Pharmaceutical Industry Collaboration and Operations</a> </div><div> <a href="/inmed-pharmaceuticals-inc-s-nasdaq-inm-inm-901-a-promising-new-candidate-for-alzheimers-therapy/">InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Therapy</a> </div><div> <a href="/clene-inc-nasdaq-clnn-presents-promising-preliminary-data-on-cnm-au8r-for-rett-syndrome-treatment/">Clene Inc. (CLNN) Presents Promising Preliminary Data on CNM-Au8(R) for Rett Syndrome Treatment</a> </div>   <p></p>   <p></p>  </div> </div> </div> </div> <div class="breadcrumb"><div class="container"><span><span><a href="https://tinygems.com/">Home</a></span> / <span><a href="https://tinygems.com/newsroom/newsroom-articles/">NewsRoom Articles</a></span> / <span class="breadcrumb_last" aria-current="page">Calidi Biotherapeutics Inc. (NYSE American: CLDI) Shares Data Supporting Innovative Proprietary Systemic Antitumor Platform</span></span></div></div>  <div class="content"> <div class="container"> <article id="post-40379" class="post-40379 post type-post status-publish format-standard hentry category-tinygem"> <header class="entry-header"> <h1 class="entry-title">Calidi Biotherapeutics Inc. (NYSE American: CLDI) Shares Data Supporting Innovative Proprietary Systemic Antitumor Platform</h1> <p class="article-date">November 22, 2024</p> </header> <div class="ad-leader"></div> <div class="single-article-left"> <div class="entry-content"> <ul> <li>“In 2024, over 611,000 deaths from cancer are projected for the U.S.,” the ACA reported. “That’s more than 1,600 deaths from cancer each day.”</li> <li>Calidi Biotherapeutics’ RTNova (“CLD-400”) is an innovative systemic antitumor enveloped virotherapy, designed to unlock new possibilities in cancer therapy.</li> <li>RTNova offers a systemic approach that enables providers to target and treat metastatic tumors that were previously untouchable.</li> </ul> <p><strong>T</strong>he American Cancer Society (“ACA”) has projected that 2024 will be the first year ever to see two million people diagnosed with cancer, which remains the second leading cause of death in the United States, after heart disease (<a href="https://ibn.fm/ADo2Q" target="_blank" rel="noreferrer noopener">https://ibn.fm/ADo2Q</a>). Companies such as <a href="https://www.investorbrandnetwork.com/clients/calidi-biotherapeutics-inc/" target="_blank" rel="noreferrer noopener">Calidi Biotherapeutics (NYSE American: CLDI)</a> are working hard to discover more effective treatments to curb the rising numbers. Calidi recently presented key data at two prominent scientific conferences regarding its new generation of targeted antitumor virotherapies and viral vectors (<a href="https://ibn.fm/9johm" target="_blank" rel="noreferrer noopener">https://ibn.fm/9johm</a>).</p> <p>“Over the last 30 years, the risk of dying from cancer has steadily declined, sparing some four million lives in the United States,” the ACA reported. “This downward trend can partially be explained by big wins in smoking cessation, early cancer detection and treatment advancements. Cancer incidence, however, is on the rise for many common cancers. In the coming year, we’re expecting to hit a bleak milestone — the first time new cases of cancer in the U.S. are expected to cross the two-million mark. That’s almost 5,500 cancer diagnoses a day.”</p> <p>The report noted that the upward trend is impacted by the aging and growth of the population and by a rise in diagnoses of six of the 10 most common cancers: breast, prostate, endometrial, pancreatic, kidney and melanoma. The other four top-10 cancers are lung, colon and rectum, bladder, and non-Hodgkin lymphoma.</p> <p>“In 2024, over 611,000 deaths from cancer are projected for the U.S.,” the report stated. “That’s more than 1,600 deaths from cancer each day.”</p> <p>Developing new and improved cancer therapies is essential to enhance patient outcomes, reduce side effects and address the complexities of different cancer types. Ground-breaking treatments can provide more effective personalized care, targeting tumors while sparing healthy cells. Advances in immunotherapy, targeted therapies and precision medicine hold the potential to transform cancer from a life-threatening disease to a manageable condition. Additionally, with cancer incidence rising globally, continued research and development are critical to meeting the growing demand for accessible, life-saving treatments and improving the quality of life for millions.</p> <p>Calidi Biotherapeutics’ RTNova (“CLD-400”) is an innovative systemic antitumor enveloped virotherapy, designed to unlock new possibilities in cancer therapy. The platform addresses challenges presented by untargetable and untreatable metastatic diseases and offers a possible potential transformative solution with wide-ranging applications. The company shared key information about RTNova at two recent conferences: the International Oncolytic Virotherapy Conference (“IOVC”) in Rotterdam, Netherlands, which was held Oct. 27–30, 2024, and Immuno U.S. 2024 in San Diego, California, which was held Oct. 28–30. In addition, the company reported a poster featuring RTNova was presented at the annual meeting of the Society for Immunotherapy of Cancer (“SITC”), which was held in Houston Nov. 6–10.</p> <p>RTNova is a systemic treatment designed for reduced elimination by the humoral immune system. It targets multiple tumor sites, killing tumor cells while altering the tumor immune microenvironment. This novel therapeutic approach not only facilitates easier administration but also broadens the potential patient population that can benefit from this treatment.</p> <p>“RTNova represents a groundbreaking advancement in cancer therapy, offering a systemic approach that enables us to target and treat metastatic tumors that were previously untouchable,” said Antonio F. Santidrian, PhD., Calidi’s chief scientific officer. “RTNova’s ability to fundamentally change the tumor microenvironment while delivering therapeutic viruses to multiple tumor sites has the potential to unlock new possibilities for patients facing some of the most challenging cancers. Ultimately, we believe RTNova has the potential to transform how we address previously untreatable metastatic diseases.”</p> <p>Calidi Biotherapeutics is a clinical-stage, immuno-oncology company with proprietary technology designed to arm the immune system to fight cancer. Calidi’s novel stem-cell-based platforms are utilizing potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in multiple oncology indications, including high-grade gliomas and solid tumors. Calidi’s clinical-stage, off-the-shelf, universal cell-based delivery platforms are designed to protect, amplify and potentiate oncolytic viruses, leading to enhanced efficacy and improved patient safety. Calidi’s preclinical off-the-shelf enveloped virotherapies are designed to target disseminated solid tumors. This dual approach can potentially treat, or even prevent, metastatic disease.</p> <p>For more information, visit <a href="http://www.calidibio.com" target="_blank" rel="noreferrer noopener">www.CalidiBio.com</a>.</p> <p><strong>NOTE TO INVESTORS:</strong> The latest news and updates relating to CLDI are available in the company’s newsroom at <a href="https://ibn.fm/CLDI" target="_blank" rel="noreferrer noopener">https://ibn.fm/CLDI</a></p> <p><strong>About TinyGems</strong></p> <p><a href="https://tinygems.com/" target="_blank" rel="noreferrer noopener">TinyGems</a> is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 60+ brands within the <a href="https://www.investorbrandnetwork.com/dynamic-brand-portfolio/" target="_blank" rel="noreferrer noopener"><strong>Dynamic Brand Portfolio</strong></a> @ <a href="https://www.investorbrandnetwork.com/" target="_blank" rel="noreferrer noopener"><strong>IBN</strong></a> that delivers<strong>:</strong> (1) access to a vast network of wire solutions via <a href="https://www.investorwire.com/" target="_blank" rel="noreferrer noopener">InvestorWire</a> to efficiently and effectively reach a myriad of target markets, demographics and diverse industries<strong>;</strong> (2) article and <a href="https://www.investorbrandnetwork.com/solutions/press-distribution-via-investorwire/syndication-partners/" target="_blank" rel="noreferrer noopener">editorial syndication to 5,000+ outlets</a><strong>;</strong> (3) enhanced <a href="https://www.investorwire.com/investorwire-press-distribution/press-release-enhancement/" target="_blank" rel="noreferrer noopener">press release enhancement</a> to ensure maximum impact<strong>;</strong> (4) <a href="https://www.investorbrandnetwork.com/social-media-network/" target="_blank" rel="noreferrer noopener">social media distribution</a> via IBN to millions of social media followers<strong>;</strong> and (5) a full array of tailored <a href="https://www.investorbrandnetwork.com/solutions/" target="_blank" rel="noreferrer noopener">corporate communications solutions</a>. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.</p> <p><strong>To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)</strong></p> <p>For more information, please visit <a href="https://tinygems.com/" target="_blank" rel="noreferrer noopener">https://www.TinyGems.com</a></p> <p>Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: <a href="https://tinygems.com/Disclaimer" target="_blank" rel="noreferrer noopener">https://www.TinyGems.com/Disclaimer</a></p> <p>TinyGems<br>Los Angeles, CA<br><a href="https://tinygems.com/" target="_blank" rel="noreferrer noopener">www.TinyGems.com</a><br>310.299.1717 Office<br><a href="mailto:Editor@TinyGems.com" target="_blank" rel="noreferrer noopener">Editor@TinyGems.com</a></p> <p>TinyGems is powered by <a href="https://www.investorbrandnetwork.com/" target="_blank" rel="noreferrer noopener">IBN</a></p> </div> <nav class="navigation post-navigation" aria-label="Posts"> <h2 class="screen-reader-text">Post navigation</h2> <div class="nav-links"><div class="nav-previous"><a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-hires-new-ceo-amid-shift-in-focus-to-pharmaceutical-industry-collaboration-and-operations/" rel="prev"><span class="meta-nav" aria-hidden="true">Previous</span> <span class="screen-reader-text">Previous post:</span> <span class="post-title">Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires New CEO Amid Shift in Focus to Pharmaceutical Industry Collaboration and Operations</span></a></div></div> </nav> </div> <div class="single-article-right"> <div class="ad-sidebar"></div> <aside id="secondary" class="sidebar widget-area" role="complementary"> <section id="recent-posts-2" class="widget widget_recent_entries"> <h2 class="widget-title">Recent Articles</h2> <ul> <li> <a href="https://tinygems.com/calidi-biotherapeutics-inc-nyse-american-cldi-shares-data-supporting-innovative-proprietary-systemic-antitumor-platform/" aria-current="page">Calidi Biotherapeutics Inc. (NYSE American: CLDI) Shares Data Supporting Innovative Proprietary Systemic Antitumor Platform</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-hires-new-ceo-amid-shift-in-focus-to-pharmaceutical-industry-collaboration-and-operations/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires New CEO Amid Shift in Focus to Pharmaceutical Industry Collaboration and Operations</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-demonstrates-continued-dehydratechtm-liraglutide-performance-with-ongoing-glp-1-diabetes-animal-study/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Demonstrates Continued DehydraTECH(TM)-Liraglutide Performance with Ongoing GLP-1 Diabetes Animal Study</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-yields-extremely-interesting-results-for-dehydratechtm-liraglutide-in-ongoing-diabetes-animal-study/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Yields “Extremely Interesting” Results for DehydraTECH(TM) Liraglutide in Ongoing Diabetes Animal Study</a> </li> <li> <a href="https://tinygems.com/inmed-pharmaceuticals-inc-s-nasdaq-inm-inm-901-a-promising-new-candidate-for-alzheimers-therapy/">InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Therapy</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-validates-technologys-superiority-moving-closer-to-a-share-in-the-global-diabetes-treatment-market/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Validates Technology’s Superiority, Moving Closer to a Share in the Global Diabetes Treatment Market</a> </li> <li> <a href="https://tinygems.com/inmed-pharmaceuticals-inc-nasdaq-inm-reports-promising-long-term-results-for-alzheimers-drug-inm-901/">InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer’s Drug INM-901</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-targeting-oral-glp-1-alternatives-for-diabetes-and-obesity-treatment/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Oral GLP-1 Alternatives for Diabetes and Obesity Treatment</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-releases-q3-2024-financial-results-offers-a-roadmap-for-its-key-glp-1-study-program/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Q3 2024 Financial Results; Offers a Roadmap for its Key GLP-1 Study Program</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-exploring-alternative-diabetes-and-obesity-treatments/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Alternative Diabetes and Obesity Treatments</a> </li> </ul> </section> </aside> <h2>Archives</h2> <div class="selectamonth">Select A Month</div> <div class="sam-outer-container"> <div class="sam-inner-container"> <div class="sam-panel"> <li><a href='https://tinygems.com/2024/11/'>November 2024</a></li> <li><a href='https://tinygems.com/2024/09/'>September 2024</a></li> <li><a href='https://tinygems.com/2024/08/'>August 2024</a></li> <li><a href='https://tinygems.com/2024/07/'>July 2024</a></li> <li><a href='https://tinygems.com/2024/06/'>June 2024</a></li> <li><a href='https://tinygems.com/2024/05/'>May 2024</a></li> <li><a href='https://tinygems.com/2024/04/'>April 2024</a></li> <li><a href='https://tinygems.com/2024/03/'>March 2024</a></li> <li><a href='https://tinygems.com/2024/02/'>February 2024</a></li> <li><a href='https://tinygems.com/2024/01/'>January 2024</a></li> <li><a href='https://tinygems.com/2023/12/'>December 2023</a></li> <li><a href='https://tinygems.com/2023/11/'>November 2023</a></li> <li><a href='https://tinygems.com/2023/10/'>October 2023</a></li> <li><a href='https://tinygems.com/2023/09/'>September 2023</a></li> <li><a href='https://tinygems.com/2023/08/'>August 2023</a></li> <li><a href='https://tinygems.com/2023/07/'>July 2023</a></li> <li><a href='https://tinygems.com/2023/06/'>June 2023</a></li> <li><a href='https://tinygems.com/2023/05/'>May 2023</a></li> <li><a href='https://tinygems.com/2023/04/'>April 2023</a></li> <li><a href='https://tinygems.com/2023/03/'>March 2023</a></li> <li><a href='https://tinygems.com/2023/02/'>February 2023</a></li> <li><a href='https://tinygems.com/2023/01/'>January 2023</a></li> <li><a href='https://tinygems.com/2022/12/'>December 2022</a></li> <li><a href='https://tinygems.com/2022/11/'>November 2022</a></li> <li><a href='https://tinygems.com/2022/10/'>October 2022</a></li> <li><a href='https://tinygems.com/2022/09/'>September 2022</a></li> <li><a href='https://tinygems.com/2022/08/'>August 2022</a></li> <li><a href='https://tinygems.com/2022/07/'>July 2022</a></li> <li><a href='https://tinygems.com/2022/06/'>June 2022</a></li> <li><a href='https://tinygems.com/2022/05/'>May 2022</a></li> </div> </div> </div> </div> </article> </div> </div>   <div class="red-panel"> <div class="container"> <p>Contact us: <span>(310) 299-1717</span></p> </div> </div>  <div class="footer"> <div class="container"> <div class="quarter"> <a href="https://tinygems.com/"><img src="https://tinygems.com/wp-content/themes/tinygems/images/tinygems-white.png" alt="TinyGems" title="TinyGems"/></a> <h6><a href="https://tinygems.com/">TinyGems</a></h6> <p>8033 Sunset Blvd. Suite TG-1037 <br/>Los Angeles, CA 90046 <br/>(310) 299-1717</p> <ul class="social"> <li class="twitter"><a href="https://twitter.com/tinygems" target="_blank" rel="nofollow"></a></li> <li class="linkedin"><a href="https://www.linkedin.com/company/5133985?trk=tyah&trkInfo=tarId%3A1402372889813%2Ctas%3Atinygem%2Cidx%3A1-1-1" target="_blank" rel="nofollow"></a></li> <li class="facebook"><a href="https://www.facebook.com/tinygems.net" target="_blank" rel="nofollow"></a></li> </ul> </div> <div class="quarter"> <div class="menu-footer-solutions-container"><ul id="menu-footer-solutions" class="menu"><li id="menu-item-31334" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-31334"><a href="https://tinygems.com/tiny-gems/">Tiny Gems</a></li> <li id="menu-item-33891" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-33891"><a href="https://tinygems.com/newsroom/">NewsRoom</a></li> <li id="menu-item-34479" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-34479"><a href="https://tinygems.com/newsletter-archives/">Newsletter Archives</a></li> <li id="menu-item-34873" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-34873"><a target="_blank" rel="noopener" href="https://www.investorbrandnetwork.com/events/">Events</a></li> </ul></div> </div> <div class="quarter"> <div class="menu-footer-other-container"><ul id="menu-footer-other" class="menu"><li id="menu-item-34480" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-34480"><a href="https://tinygems.com/about/">About</a></li> <li id="menu-item-34481" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-privacy-policy menu-item-34481"><a rel="privacy-policy" href="https://tinygems.com/disclaimer/">Disclaimer</a></li> <li id="menu-item-34482" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-34482"><a href="https://tinygems.com/contact/">Contact</a></li> </ul></div> </div> <div class="quarter"> <div class="quickquote"> <h6>Quote / Research</h6> <input type="text" id="SymbolField" placeholder="Enter Symbol"> <a href="" class="getQuote">Get Quote</a> <h6 class="sitesearch">Site Search</h6> <form role="search" method="get" class="search-form" action="https://tinygems.com/"> <input type="search" class="search-field" placeholder="Search Term …" value="" name="s" /> <button type="submit" class="search-submit">Search</button> </form> </div> </div> <div class="copyright"> <p>Copyright © <script language="JavaScript" type="text/javascript"> var d=new Date(); yr=d.getFullYear(); if (yr!=2020) document.write("2020 - "+yr); else {document.write(""+yr);} </script>. TinyGems / 8033 Sunset Blvd. Suite TG-1037, Los Angeles, CA 90046 (310) 299-1717 / <a href="/disclaimer">Disclaimers</a></p> <p class="captcha-statement">Forms are protected by reCAPTCHA and the Google <a href="https://policies.google.com/privacy" target="_blank" rel="noopener noreferrer">Privacy Policy</a> and <a href="https://policies.google.com/terms" target="_blank" rel="noopener noreferrer">Terms of Service</a> apply.</p> </div> </div> </div>  <script id="tawk-script" type="text/javascript"> var Tawk_API = Tawk_API || {}; var Tawk_LoadStart=new Date(); (function(){ var s1 = document.createElement( 'script' ),s0=document.getElementsByTagName( 'script' )[0]; s1.async = true; s1.src = 'https://embed.tawk.to/6310b06854f06e12d8922d61/1gbsj268n'; s1.charset = 'UTF-8'; s1.setAttribute( 'crossorigin','*' ); s0.parentNode.insertBefore( s1, s0 ); })(); </script>  <script type="text/javascript" id="ges_angular_script-js-extra"> /* <![CDATA[ */ var wp_data = {"ajaxurl":"https:\/\/tinygems.com\/wp-admin\/admin-ajax.php","symbol":null}; /* ]]> */ </script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/ang-script.js?1732373182" id="ges_angular_script-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/plugins/contact-form-7/includes/swv/js/index.js" id="swv-js"></script> <script type="text/javascript" id="contact-form-7-js-extra"> /* <![CDATA[ */ var wpcf7 = {"api":{"root":"https:\/\/tinygems.com\/wp-json\/","namespace":"contact-form-7\/v1"}}; /* ]]> */ </script> <script type="text/javascript" src="https://tinygems.com/wp-content/plugins/contact-form-7/includes/js/index.js" id="contact-form-7-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/skip-link-focus-fix.js" id="tinygems-skip-link-focus-fix-js"></script> <script type="text/javascript" id="tinygems-script-js-extra"> /* <![CDATA[ */ var screenReaderText = {"expand":"expand child menu","collapse":"collapse child menu"}; /* ]]> */ </script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/functions.js" id="tinygems-script-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/js.cookie.min.js" id="tinygems-cookies-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/custom.js" id="tinygems-myscripts-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/jquery.cycle2.min.js" id="tinygems-cycle-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/jquery.cycle2.scrollVert.min.js" id="tinygems-cycle-vert-js"></script> <script type="text/javascript" src="https://www.google.com/recaptcha/api.js?render=6LdoYukfAAAAANjIa2I8Gxc0Ty_xdMITmbwMhOmA" id="google-recaptcha-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/dist/vendor/wp-polyfill-inert.min.js" id="wp-polyfill-inert-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/dist/vendor/regenerator-runtime.min.js" id="regenerator-runtime-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/dist/vendor/wp-polyfill.min.js" id="wp-polyfill-js"></script> <script type="text/javascript" id="wpcf7-recaptcha-js-extra"> /* <![CDATA[ */ var wpcf7_recaptcha = {"sitekey":"6LdoYukfAAAAANjIa2I8Gxc0Ty_xdMITmbwMhOmA","actions":{"homepage":"homepage","contactform":"contactform"}}; /* ]]> */ </script> <script type="text/javascript" src="https://tinygems.com/wp-content/plugins/contact-form-7/modules/recaptcha/index.js" id="wpcf7-recaptcha-js"></script> </body> </html>